Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From Daily World Feed

North Korea's Kim meets Chinese envoy after deadly bus crash

Apr 24, 2018

BEIJING — North Korean leader Kim Jong Un has met with China's ambassador and visited a hospital where Chinese tourists were being treated after a deadly bus crash. The crash Sunday evening killed 32 Chinese and four North Koreans, and two Chinese were seriously injured. China's official Xinhua News Agency said late Monday that the tourist bus fell from a bridge in North Hwanghae province in southern North Korea. Photos provided by the North Korean government on Tuesday showed Kim meeting with Ambassador Li Jinjun at the hospital and at the Chinese Embassy. China's Foreign Ministry said a medical team...

Punjab pulls off sensational 4-run win over Delhi in IPL

Apr 24, 2018

NEW DELHI — Needing five runs off the last ball to win, Shreyas Iyer went for the big hit. And holed out at long off, allowing Kings XI Punjab to sensationally beat Delhi Daredevils by four runs in the Indian Premier League on Monday. Delhi, chasing 144 to win, ended up at 139-8 and on the bottom of the table with only one win from five matches. Punjab swiftly moved into a share of the lead with Chennai Super Kings after its fourth win from five games. For the last over, Punjab skipper Ravichandran Ashwin gave the ball to 17-year-old...

India's Infosys to renew focus on digital services

Apr 24, 2018

By Sankalp PhartiyalMUMBAI (Reuters) - Infosys Ltd, India's second-biggest IT firm, plans to renew its focus on digital services as it looks to boost growth amid shrinking profit margins in its legacy business and rising competition from local and international rivals.Digital services - such as cloud, big data and analytics which accounted for more than a quarter of Infosys' revenue in year to March 2018 - are a massive opportunity, Chief Executive Salil Parekh said on Monday at the company's first analyst meeting in nearly two years."The idea is - this is a huge market, how can we be more...

Amir's departure for Pakistan tour delayed by visa problem

Apr 24, 2018

ISLAMABAD — Fast bowler Mohammad Amir's departure for the Pakistan cricket team's tour of Ireland and Britain has been delayed due to a problem in obtaining his visa. "Amir could not travel with the team," Pakistan Cricket Board spokesman Amjad Bhatti confirmed to The Associated Press. "There's some procedural issue which I hope will be resolved by Wednesday." Bhatti could not elaborate what exactly the issue was, but he was optimistic that Amir will get his visa within two days. Local media reported Amir had already applied for a longer term spouse visa because his wife is a British national...

Kabul blast highlights risk to long-delayed Afghan vote

Apr 24, 2018

By James MackenzieKABUL (Reuters) - Afghan officials pledged that Sunday's deadly suicide bombing of a voter center in Kabul will not derail preparations for this year's parliamentary elections but the attack has underlined the risks to an operation already clouded by doubt.More than 50 people queuing to receive identity cards for the ballot were killed in the blast, by far the most serious of a series of attacks on the registration process officially launched earlier this month."The incident which happened yesterday has caused problems," said Soma Ziarmal, an elections officer helping supervise a center in the capital. "But we're urging...

About Us

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Contact us: sales[at]dailyworldfeed.com

Subscribe Now!